Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Jewell

Showing results (71-80 of 337) with videos related to

Pageof 34
Sort By:
Journal of Clinical Pathology|March 1, 1987
Class II antigen (HLA-DR) expression by intestinal epithelial cells in inflammatory diseases of colonG B McDonald, D P Jewell
Alimentary Pharmacology & Therapeutics|January 1, 1996
Cytokines and mechanisms of action of glucocorticoids and aminosalicylates in the treatment of ulcerative colitis and Crohn's diseaseM J Zimmerman, D P Jewell
Gastroenterology|August 1, 1993
Mechanisms of diarrhea in ulcerative colitisS P Travis, D P Jewell
Annals of Medicine|October 1, 1991
The management of acute severe ulcerative colitisH R Dalton, D P Jewell
Clinical and Experimental Immunology|July 1, 1985
The nature of the natural killer (NK) cell of human intestinal mucosa and mesenteric lymph nodeP R Gibson, D P Jewell
Mediators of Inflammation|January 1, 1994
The role of cytokines in inflammatory bowel diseaseG Radford-Smith, D P Jewell
British Medical Journal|December 14, 1974
Azathioprine in ulcerative colitis: final report on controlled therapeutic trialD P Jewell, S C Truelove
Gut|April 1, 1972
Azathioprine in ulcerative colitisD P Jewell, S C Truelove
Gut|November 1, 1972
Reaginic hypersensitivity in ulcerative colitisD P Jewell, S C Truelove
Gut|July 13, 2005
Risks and benefits of azathioprine therapyD P B McGovern, D P Jewell
Pageof 34

Showing results (71-80 of 337) with videos related to

Sort By:
Pageof 34
Journal of Clinical Pathology|March 1, 1987
Class II antigen (HLA-DR) expression by intestinal epithelial cells in inflammatory diseases of colonG B McDonald, D P Jewell
Alimentary Pharmacology & Therapeutics|January 1, 1996
Cytokines and mechanisms of action of glucocorticoids and aminosalicylates in the treatment of ulcerative colitis and Crohn's diseaseM J Zimmerman, D P Jewell
Gastroenterology|August 1, 1993
Mechanisms of diarrhea in ulcerative colitisS P Travis, D P Jewell
Annals of Medicine|October 1, 1991
The management of acute severe ulcerative colitisH R Dalton, D P Jewell
Clinical and Experimental Immunology|July 1, 1985
The nature of the natural killer (NK) cell of human intestinal mucosa and mesenteric lymph nodeP R Gibson, D P Jewell
Mediators of Inflammation|January 1, 1994
The role of cytokines in inflammatory bowel diseaseG Radford-Smith, D P Jewell
British Medical Journal|December 14, 1974
Azathioprine in ulcerative colitis: final report on controlled therapeutic trialD P Jewell, S C Truelove
Gut|April 1, 1972
Azathioprine in ulcerative colitisD P Jewell, S C Truelove
Gut|November 1, 1972
Reaginic hypersensitivity in ulcerative colitisD P Jewell, S C Truelove
Gut|July 13, 2005
Risks and benefits of azathioprine therapyD P B McGovern, D P Jewell
Pageof 34